TMEM161B
Transmembrane protein 161B
Also known as: MGC33214, T161B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NDZ6
- Gene
- TMEM161B
- Ensembl
- ENSG00000164180
- Chromosome
- 5
- Canonical length
- 487 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable nucleic acid binding activity. Predicted to be involved in regulation of cardiac muscle cell action potential and regulation of heart rate. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
487 residues, UniProt reviewed canonical sequence.
>Q8NDZ6|TMEM161B
1 MGVIGIQLVV TMVMASVMQK IIPHYSLARW LLCNGSLRWY QHPTEEELRI LAGKQQKGKT
61 KKDRKYNGHI ESKPLTIPKD IDLHLETKSV TEVDTLALHY FPEYQWLVDF TVAATVVYLV
121 TEVYYNFMKP TQEMNISLVW CLLVLSFAIK VLFSLTTHYF KVEDGGERSV CVTFGFFFFV
181 KAMAVLIVTE NYLEFGLETG FTNFSDSAMQ FLEKQGLESQ SPVSKLTFKF FLAIFCSFIG
241 AFLTFPGLRL AQMHLDALNL ATEKITQTLL HINFLAPLFM VLLWVKPITK DYIMNPPLGK
301 ESIPLMTEAT FDTLRLWLII LLCALRLAMM RSHLQAYLNL AQKCVDQMKK EAGRISTVEL
361 QKMVARVFYY LCVIALQYVA PLVMLLHTTL LLKTLGNHSW GIYPESISTL PVDNSLLSNS
421 VYSELPSAEG KMKVTVTQIT VALSSLKNIF TPLLFRGLLS FLTWWIAACL FSTSLFGLFY
481 HQYLTVALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM161B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 38 nTPM
- thyroid gland: 31 nTPM
- stomach: 24 nTPM
- epididymis: 22 nTPM
- pancreas: 22 nTPM
- breast: 20 nTPM
Single-cell type
- parietal cells: 203 nCPM
- choroid plexus epithelial cells: 92 nCPM
- distal convoluted tubule cells: 79 nCPM
- lactotrophs: 72 nCPM
- thyrotrophs: 71 nCPM
- cardiomyocytes: 69 nCPM
Immune cell
- MAIT T-cell: 3 nTPM
- NK-cell: 3 nTPM
- gdT-cell: 2.9 nTPM
- intermediate monocyte: 2.8 nTPM
- plasmacytoid DC: 2.6 nTPM
- naive CD4 T-cell: 2.5 nTPM
Brain region
- cerebellum: 27 nTPM
- cerebral cortex: 25 nTPM
- white matter: 24 nTPM
- basal ganglia: 23 nTPM
- hippocampal formation: 21 nTPM
- hypothalamus: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TMEM161B.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 57 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM161B as an antibody target. Whether an autoantibody or antibody against TMEM161B could matter depends on whether native TMEM161B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM161B is annotated at the cell surface, where native TMEM161B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM161B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...